Literature DB >> 17191023

High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.

Ling Li1, Gangyi Yang, Qingming Li, Yi Tang, Ke Li.   

Abstract

AIMS: In animal models, both an acute elevation in plasma free fatty acid (FFA) via intravenous infusion of a lipid emulsion and a chronic elevation in plasma FFA via high-fat feeding have been shown to induce skeletal muscle and liver insulin resistance. However, there have been very few studies comparing the effects of high-fat- and lipid-induced insulin resistance on glucose metabolism and adipocytokines.
METHODS: In the current study, we used lipid infusion and a high-fat feed in combination with the hyperinsulinemic-euglycemic clamp technique to assess the impact of acute and chronically elevated FFA levels on overall glucose metabolism and insulin action; two adipocytokines, resistin and adiponectin, were used.
RESULTS: At baseline, plasma FFA levels were significantly increased in the high-fat diet (HF) group compared to the control group (p < 0.05). During clamp steady-state, the FFA levels were reduced by approximately 25% in the control and approximately 48% in the HF groups. In contrast, there was a significant increase in the plasma FFA level in the lipid-infused group (from 0.82 +/- 0.03 to 2.87 +/- 0.18 mmol/l). The glucose infusion rates (GIRs) in the HF and lipid groups were obviously lower than in the control group (p < 0.01). Moreover, GIR was lower in the lipid group compared with the HF group (p < 0.05). The rate of glucose disappearance (G(Rd)) was significantly lower in the lipid group compared with the control group. Hepatic glucose production in the control group was suppressed by approximately 15% compared with the HF and lipid groups where it was suppressed by only approximately 72 and approximately 91%, respectively. The resistin level of muscle tissues in the lipid group was significantly higher compared with the control and HF groups (both p < 0.05). After the insulin clamp, the circulating adiponectin level was significantly decreased in the lipid group compared with the control and HF groups (p < 0.05).
CONCLUSIONS: Lipid infusion, which was more effective than a high-fat diet, can induce peripheral and hepatic insulin resistance in rats. Insulin-induced resistance might be associated with elevated resistin and decreased adiponectin. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17191023     DOI: 10.1159/000098141

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  10 in total

Review 1.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

2.  Obesity and type 2 diabetes in rats are associated with altered brain glycogen and amino-acid homeostasis.

Authors:  Helle M Sickmann; Helle S Waagepetersen; Arne Schousboe; Andrew J Benie; Stephan D Bouman
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

3.  Comparison of three commercially available prescription diet regimens on short-term post-prandial serum glucose and insulin concentrations in healthy cats.

Authors:  A Mori; T Sako; P Lee; Y Nishimaki; H Fukuta; H Mizutani; T Honjo; T Arai
Journal:  Vet Res Commun       Date:  2009-03-26       Impact factor: 2.459

4.  Long-term obesity promotes alterations in diastolic function induced by reduction of phospholamban phosphorylation at serine-16 without affecting calcium handling.

Authors:  Ana Paula Lima-Leopoldo; André S Leopoldo; Danielle C T da Silva; André F do Nascimento; Dijon H S de Campos; Renata A M Luvizotto; Adriana F de Deus; Paula P Freire; Alessandra Medeiros; Katashi Okoshi; Antonio C Cicogna
Journal:  J Appl Physiol (1985)       Date:  2014-06-26

5.  Resolving the sources of plasma glucose excursions following a glucose tolerance test in the rat with deuterated water and [U-13C]glucose.

Authors:  Teresa C Delgado; Cristina Barosa; Patrícia M Nunes; Sebastián Cerdán; Carlos F G C Geraldes; John G Jones
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

6.  Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.

Authors:  Byeong Tak Jeon; Eun Ae Jeong; Hyun Joo Shin; Younghyurk Lee; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  Diabetes       Date:  2012-02-23       Impact factor: 9.461

7.  Influence of term of exposure to high-fat diet-induced obesity on myocardial collagen type I and III.

Authors:  Danielle Cristina Tomaz da Silva; Ana Paula Lima-Leopoldo; André Soares Leopoldo; Dijon Henrique Salomé de Campos; André Ferreira do Nascimento; Silvio Assis de Oliveira Junior; Carlos Roberto Padovani; Antonio Carlos Cicogna
Journal:  Arq Bras Cardiol       Date:  2013-11-09       Impact factor: 2.000

8.  Obesity preserves myocardial function during blockade of the glycolytic pathway.

Authors:  Dijon Henrique Salomé de Campos; André Soares Leopoldo; Ana Paula Lima-Leopoldo; André Ferreira do Nascimento; Silvio Assis de Oliveira-Junior; Danielle Cristina Tomaz da Silva; Mario Mateus Sugizaki; Carlos Roberto Padovani; Antonio Carlos Cicogna
Journal:  Arq Bras Cardiol       Date:  2014-09-12       Impact factor: 2.000

9.  Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism.

Authors:  Christoph Dahlhoff; Charles Desmarchelier; Manuela Sailer; Rainer W Fürst; Alexander Haag; Susanne E Ulbrich; Björn Hummel; Rima Obeid; Jürgen Geisel; Bernhard L Bader; Hannelore Daniel
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Modified high-sucrose diet-induced abdominally obese and normal-weight rats developed high plasma free fatty acid and insulin resistance.

Authors:  Li Cao; Xuehui Liu; Hongyi Cao; Qingguo Lv; Nanwei Tong
Journal:  Oxid Med Cell Longev       Date:  2012-12-25       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.